Deborah Weinstein

Deborah Weinstein has covered politics, crime, and healthcare policies for various news outlets including Medical Marketing & Media, where she specializes in Obesity, Alzheimer’s disease and healthcare costs.

Most Recent Articles by Deborah Weinstein

Five things for pharma marketers to know: Tuesday, December 16

Five things for pharma marketers to know: Tuesday, December 16

Bayer consolidates OTC creative portfolio; Genentech R&D head steps down; Novartis receives approval for orphan drug.

Sanofi, Regeneron field  pre-launch cholesterol IQ poll

Sanofi, Regeneron field pre-launch cholesterol IQ poll

The drugmakers, who have an experimental cholesterol medication in the works, are asking consumers what they know about heart health.

FDA 2014 approvals outpace those of 2013

FDA 2014 approvals outpace those of 2013

The regulator noted in its early 2014 retrospective that it set a high mark for the number of approved rare disease drugs this year, and that insufficient information is the reason many breakthrough status requests get bounced.

Five things for pharma marketers to know: Monday, December 15

Five things for pharma marketers to know: Monday, December 15

United Healthcare tests an all-in-one cancer payment model, Pfizer inks a worldwide commercialization license for a human growth factor hormone, and the Commonwealth Fund grades Medicare as the program nears its 50th.

Five things for pharma marketers to know, Thursday, December 11

Five things for pharma marketers to know, Thursday, December 11

Philadelphia Transportation Authority sues Gilead over Sovaldi sticker shock; Digital marketing tactics raise privacy concerns; another patent cliff is on the horizon.

More Articles by Deborah Weinstein


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.

Email Newsletters